JUN 08, 2021 2:45 PM PDT

Simple Blood Test Can Detect Depression and Underlying Neurodegeneration

WRITTEN BY: Annie Lennon

Researchers led by King’s College London have found that levels of a protein known as neurofilament light chain (Nfl) in the blood can indicate whether people have neurodegenerative diseases. The research could be used to diagnose conditions inducing Down’s syndrome, dementia and motor neuron disease when clinical symptoms are inconclusive. 

Currently, doctors diagnose neurodegenerative disorders from samples of cerebrospinal fluid taken from the fluid around the brain and spinal column. Extracting this fluid requires an invasive procedure called a lumbar puncture. 

Blood tests offer a less invasive solution to finding biomarkers. A central and irreversible characteristic of neurodegenerative disorders is damage to the nerve fibre, leading to the release of Nfl. 

To see whether levels of this protein could be detected and used to predict neurodegeneration, the researchers examined 3138 people. They included people with no cognitive impairment, some with neurodegenerative disorders, Down's syndrome and depression. 

The researchers found that concentrations of Nfl were higher across all neurodegenerative disorders compared to those with no cognitive impairment. The highest levels however were detected among those with Down’s syndrome, dementia, motor neuron disease and frontotemporal dementia. 

The researchers found that while the biomarker could not be used to differentiate between all the disorders, it could provide insight into subtypes of various disorders. For example, among those with Parkinson’s disorder, higher Nfl levels indicated atypical Parkinaons’s disorder. Levels of the biomarker could also be used to distinguish between neurodegenerative disorders and depression.

 "This study shows that neurofilament light chain levels were particularly increased in adults with Down syndrome who have a genetic predisposition for Alzheimer’s disease. Furthermore, we showed that those individuals with a dementia diagnosis following onset of Alzheimer’s disease had higher levels than those who did not.” says Andre Strydom, co-author of the study. 

“This suggests that the new marker could potentially be used to improve the diagnosis of Alzheimer’s in people with Down syndrome, as well as to be used as biomarker to show whether treatments are effective or not. It is exciting that all that could be needed is a simple blood test, which is better tolerated in Down syndrome individuals than brain scans.”

 

Sources: Neuroscience NewsNature

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
JUL 18, 2021
Neuroscience
How Slime Molds Think Without a Brain
JUL 18, 2021
How Slime Molds Think Without a Brain
A brainless slime mold known as Physarum polycephalum uses its body to sense mechanical cues in its environment. Then, i ...
AUG 01, 2021
Technology
Actually, You DO Know You Are a Brain in a Vat: Exoskeleton Pros and Cons
AUG 01, 2021
Actually, You DO Know You Are a Brain in a Vat: Exoskeleton Pros and Cons
Exoskeletons promise mobility and enhance strength, but a new study shows they can be debilitating for the brain
JUL 29, 2021
Health & Medicine
CBD Linked WIth Better Quality of Life in Epilepsy Patients
JUL 29, 2021
CBD Linked WIth Better Quality of Life in Epilepsy Patients
People with epilepsy report better well-being when they self-medicate with cannabidiol (CBD) according to a new study pu ...
AUG 21, 2021
Neuroscience
Is Humor the Best Way to Deliver Public Health Interventions?
AUG 21, 2021
Is Humor the Best Way to Deliver Public Health Interventions?
Humor is an effective way to deliver public health interventions and influence people’s behavior around their heal ...
SEP 03, 2021
Technology
Bionic Arm Effective at Restoring "Natural" Arm Function in Amputees
SEP 03, 2021
Bionic Arm Effective at Restoring "Natural" Arm Function in Amputees
A research team at the Cleveland Clinic has developed a new mechanical arm that could help people who have received arm ...
SEP 14, 2021
Immunology
Extinguishing Fires in the Brains of MS Patients
SEP 14, 2021
Extinguishing Fires in the Brains of MS Patients
  A closer look at the brains of patients with aggressive, debilitating forms of multiple sclerosis (MS) reveals so ...
Loading Comments...